Literature DB >> 35236102

Editorial Comment.

Craig V Labbate1, Mehrad Adibi1, Surena F Matin1.   

Abstract

Entities:  

Year:  2022        PMID： 35236102     DOI： 10.1097/JU.0000000000002454.02

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  1 in total

1.  Comment on "Durability of response to primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel: OLYMPUS trial final report".

Authors:  Yuxuan Song; Yiqing Du; Caipeng Qin; Tao Xu
Journal:  World J Urol       Date:  2022-02-22       Impact factor: 4.226
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.